National Institutes of Health: Brain Diseases trials

The registry lists 19 Brain Diseases studies with National Institutes of Health as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 2No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of StrokeRecruitingNCT06615973
• Inflammatory and Infectious Diseases of the Nervous SystemRecruitingNCT02435810
• Natural History of Stroke: Cause and DevelopmentRecruitingNCT00009243
• Procedural Motor Memory in Long COVID-19CompletedNCT05746624
• PET Imaging in Chronic Traumatic EncephalopathyCompletedNCT02211820
• Study on Moebius Syndrome and Congenital Facial Weakness DisordersCompletedNCT02055248
• A Study of the Association Between Autism and Immune Changes in the BrainTerminatedNCT01322555
• Connectivity Analysis for Investigation of Auditory Impairment in EpilepsyTerminatedNCT01212068
• A Study of the Genetic Analysis of Brain DisordersCompletedNCT00645645
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)TerminatedNCT00459693Not applicable
• Clinical and Genetic Studies on HoloprosencephalyCompletedNCT00088426
• Test of A Model of Representational Knowledge Stored in the Human Prefrontal CortexCompletedNCT00024908
• Differences in Brain Processing of First and Second Languages (Korean and English)CompletedNCT00016510
• Phase II Study of Lactulose and Circadian Rhythms in Patients With CirrhosisCompletedNCT00004796Phase 2
• Study of Abnormal Blood Clotting in Children With StrokeCompletedNCT00001927
• Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy VolunteersCompletedNCT00001284
• Brain Tissue Collection for Neuropathological StudiesTerminatedNCT00001260
• A Study of Azidothymidine in HIV-Infected ChildrenCompletedNCT00000982Phase 2
• A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.WithdrawnNCT00000856Phase 1